February 2013 FDA Recall Drug by Olaax International
D-600-2013 - Marketed Without an Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Olaax International on February 12, 2013 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-600-2013

Reason for Recall
Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.
Initiated
02-12-2013
Reported
06-19-2013
Quantity
600 boxes

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide, Puerto Rico and Venezuela and Bolivia
MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL

Batch or Lot Expiration Information

Lot# All Lots